At least 10 crore people in India have diabetes. Its medicine is also very expensive. Many people cannot even afford that medicine. We want to give you such a good news that you will be happy to hear.
How the price of medicine godown?
Diabetes medicine has become cheaper. Yes, you heard it right, the medicine for diabetes which costs ₹ 60 is going to be cheaper than ₹ 10. This alarm has been given by the Modi government.
The price of medicine become 6 rupees
The Sugar medicine for diabetes which costs ₹ 60 will now be available for ₹ 9. Many poor families of India will be very happy with this good news. The government has taken a very good step for diabetic patients. The government has reduced the price of this medicine by 90%.
This question must be coming in your mind that how can this happen. How can a medicine which is available for ₹ 60 be available for ₹ 9? Let us know the clear reason for this in this article.
How many people of diabetes are in India
Diabetes is a disease which one out of every 10 people in India has. Our blood is needed the most by our heart, brain and kidneys. If a person has diabetes, then these three organs are affected the most.
10 crore patients in India
According to reports, there are more than 10 crore patients suffering from diabetes in India. Most of these people bear the cost of their medicines themselves.
Deal with Japan company
The name of the drug used to make diabetes medicine is Empagliflozin. It was made there from a German company and its patent has expired in March 2025. Now the Indian company will launch this medicine with its own brand. If the company is from India, then there will be no cost in import.
No cost stop of import
If there is no cost in import, then the common man will get the medicine at cheaper prices. Due to being an Indian company, the general public will have to pay 90% less price for this medicine, so its price will come down from ₹ 60 to nine rupees.
That’s why the price of medicine decreases. This news is going to prove most beneficial for poor families.